Amgen Inks $300M Deal For Dutch Drugmaker
Amgen Inc. said Wednesday it will pay $300 million in up-front cash and up to $1.25 billion in bonus payments for Netherlands startup Dezima Pharma BV, a deal aimed at enhancing...To view the full article, register now.
Already a subscriber? Click here to view full article